Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
419
-
Total 13F shares, excl. options
-
168,245,764
-
Shares change
-
+8,521,631
-
Total reported value, excl. options
-
$15,561,381,289
-
Value change
-
+$820,936,102
-
Put/Call ratio
-
1.23%
-
Number of buys
-
236
-
Number of sells
-
-151
-
Price
-
$92.52
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q3 2016
491 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q3 2016.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 419 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 168,245,764 shares
of 193,539,047 outstanding shares and own 86.93% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (20,216,215 shares), VANGUARD GROUP INC (12,230,286 shares), SANDS CAPITAL MANAGEMENT, LLC (10,221,282 shares), FMR LLC (10,079,541 shares), JENNISON ASSOCIATES LLC (9,702,200 shares), PRIMECAP MANAGEMENT CO/CA/ (7,108,129 shares), BAKER BROS. ADVISORS LP (4,806,483 shares), BlackRock Institutional Trust Company, N.A. (4,131,259 shares), BlackRock Fund Advisors (4,049,472 shares), and JPMORGAN CHASE & CO (3,701,061 shares).
This table shows the top 419 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.